•
Mar 31, 2023

Select Medical Q1 2023 Earnings Report

Select Medical's financial performance improved in Q1 2023 with revenue and net income increasing.

Key Takeaways

Select Medical Holdings Corporation reported a 4.1% increase in revenue to $1,665.0 million for the first quarter ended March 31, 2023, compared to $1,599.5 million for the same quarter prior year. Net income increased 52.4% to $85.3 million, compared to $55.9 million for the same quarter, prior year.

Revenue increased by 4.1% to $1,665.0 million compared to the same quarter last year.

Net income increased by 52.4% to $85.3 million compared to the same quarter last year.

Earnings per common share increased 51.3% to $0.56 compared to the same quarter last year.

The Board of Directors declared a cash dividend of $0.125 per share.

Total Revenue
$1.67B
Previous year: $1.6B
+4.1%
EPS
$0.56
Previous year: $0.37
+51.4%
Gross Profit
$246M
Previous year: $193M
+27.9%
Cash and Equivalents
$83.7M
Previous year: $131M
-36.0%
Total Assets
$7.7B
Previous year: $7.54B
+2.2%

Select Medical

Select Medical

Select Medical Revenue by Segment

Forward Guidance

Select Medical reaffirms its 2023 business outlook for revenue, expecting consolidated revenue to be in the range of $6.5 billion to $6.7 billion. The company also expects Adjusted EBITDA to be in the range of $780.0 million to $820.0 million and fully diluted earnings per common share to be in the range of $1.75 to $1.99.

Revenue & Expenses

Visualization of income flow from segment revenue to net income